Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |